Human immunodeficiency virus (HIV)
Development of thymic regulatory T cells during human immunodeficiency virus (HIV) infection
... People living with chronic human immunodeficiency virus (HIV) infection have increased Treg frequencies in peripheral blood and lymphoid tissues. TGF-~-mediated fibrosis [r] ...
170
Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin
... simian immunodeficiency virus cpz to humans has given rise to both pandemic (M) and non-pandemic (O, N and P) groups of human immunodeficiency virus type-1 ...of human-to- ...
12
Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir
... tients. Human immunodeficiency virus-induced immunosup- pression has been shown to affect levels of qAnti-HBc, but not particularly qHBcrAg [ 32 ], and longer periods of HIV infection have been ...
9
Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import
... of human immunodeficiency virus type 1 (HIV-1) is encoded by the pol gene and catalyzes integration of viral cDNA into host chromosome, an essential step in HIV-1 ...after virus entry into ...
15
Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness
... and 5 Médecins Sans Frontières France, Paris; and 6 Medical Practice Evaluation Center and Divisions of General Internal Medicine and Infectious Diseases, Massachusetts General Hospital, and Harvard Medical School, and 7 ...
9
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat’AIDS Cohort Study
... Background. We assessed prevalence of multimorbidity (MM) according to year of human immunodeficiency virus (HIV) di- agnosis in elderly people living with HIV (PLWH). Methods. This was a ...
10
IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis
... of human immunodeficiency virus-1 (HIV-1) antibodies (Abs) remains mostly correlated with their in vitro neutralizing activity engaging their Fab ...on human monocytes used as effector cells, ...
13
Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production
... Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R.A., Wingfield, P., Gallo, R.C., 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type ...
14
Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region
... Inducible human immunodeficiency virus type 1 (HIV-1) gene expression is generally mediated by the binding of NF- κ B to the enhancer κ B-binding sites in the long terminal repeat (22, 26, ...
16
Human Immunodeficiency Virus Type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest.
... in human immunodeficiency virus type 1 (HIV-1), the accessory proteins viral infectivity factor (Vif) and viral protein R (Vpr), inhibit cell-cycle progression at the G2 phase of the cell ...
9
Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis
... Human immunodeficiency virus (HIV)–infected adults and children are particularly at risk of NTM-related diseases, including respiratory and disseminated infections due to the Mycobacterium avium ...
5
View of Immune reconstitution inflammatory syndrome in Human Immunodeficiency Virus-infected patients treated with antiretroviral therapy
... for Human Immunodeficiency Virus (HIV) infected people has led to a decrease in the risk of mortality and in the occurrence of opportunistic infections ...JC virus are the main agents ...
7
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappa B and inhibitors of deacetylases: Potential perspectives for the development of therapeutic strategies
... latently human immunodeficiency virus (HIV)-infected cellular reservoirs, despite prolonged treat- ment with highly active antiretroviral therapy (HAART), rep- resents the major hurdle to ...
13
Use of human papillomavirus genotyping and biomarkers for targeted screening of anal dysplasia in human immunodeficiency virus-infected patients
... Accepted Manuscript INTRODUCTION The incidence of anal cancer has dramatically increased over the last decade in high-risk groups, including men who have sex with men (MSM), women with a previous history of cervical or ...
27
Molecular and functional studies of human immunodeficiency virus type 1 accessory protein
... Role ofthe matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. T cdl dynamics in HIV-1 infection.[r] ...
245
Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual-protease-inhibitor regimen.
... Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted du[r] ...
28
Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines.
... Human Immunodeficiency Virus Protease Inhibitors Accumulate into Cultured Human Adipocytes and Alter Expression of Adipocytokines* Received for publication, July 30, 2004, and in revised ...
8
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
... Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Déborah Hirt, Saik Urien, Elisabeth Rey, Elise Arrivé, Didier Ekouévi, ...
31
Capture and purification of Human Immunodeficiency Virus-1 virus-like particles: Convective media vs porous beads
... liths, such as baculoviruses, different influenza virus A and B sub- types and HIV-1 gag VLPs [15-17] . Also, membrane adsorbers have been successfully used for the capture and purification of bac- ulovirus and ...
12
Impact of Human Immunodeficiency Virus on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon
... 2010). Human immunode ficiency virus diagnosis was made according to national guidelines by 2 different rapid tests performed at the Akonolinga district hospital ...
10